HotalingAJHillstromRPBazellC.Sickle cell crisis and sensorineural hearing loss: Case report and discussion.Int J Pediatr Otolaryngol1989;17:207–11.
2.
TherrellBLSimmankJLWilbornM.Experience with sickle hemoglobin in the Texas Newborn Screening Program.Pediatrics1989;83:864–7.
3.
BunnHFDisorders of hemoglobin. In: BraunwaldEIsselbackerKJPetersdorfRGWilsonJDMartinJBFauciAS, eds. Harrison's principles of internal medicine. 11th ed.New York: McGraw-Hill, 1987: 1519–24.
4.
MorgensteinKMManaceEDTemporal bone histopathology in sickle cell disease.Laryngoscope1969;79:2172–80.
5.
FreidmanEMLubanNIXHererGRWilliamsI.Sickle cell anemia and hearing.Ann Otolaryngol1980;89:342–7.
6.
ToddGSergeantGLarsonM.Sensorineural hearing loss in Jamaicans with sickle cell disease.Acta Otolaryngol1973;76:268–72.
7.
UrbanGEReversible sensorineural hearing loss associated with sickle cell crisis.Laryngoscope1973;83:633–8.
8.
OrchickDJDunnJWSickle cell anemia and sudden deafness.Arch Otolaryngol1977;103:369–70.
9.
CrawfordMRGouldHJSmithWRBeckfordNGibsonRBoboL.Prevalence of hearing loss in adults with sickle cell disease.Ear Hear1991;12:349–51.
10.
WeissmanJLCurtinHDHirschBEHirschWLHigh signal from the otic labyrinth on unenhanced magnetic resonance imaging.AJNR Am J Neuroradiol1992;13:1183–7.
11.
WayneASKevySVNethanDGTransfusion management of sickle cell disease.Blood1993;81:1109–23.
12.
CharacheSLubinBReidCD, eds. Management and therapy of sickle cell disease. Bethesda, Md.: National Institutes of Health, NIH publication no. 91–2117.
13.
RogersGRDoverGJUyesakaNNoguchiCTSchechterANNeinhuisAWAugmentation by erythropoietin of the fetal-hemoglobin response to hydroxyurea in sickle cell disease.N Engl J Med1993;328:73–80.